Freedom Day Solutions, LLC Eli Lilly & CO Transaction History

Freedom Day Solutions, LLC

$280 Million
Q1 2024

A detailed history of Freedom Day Solutions, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Freedom Day Solutions, LLC holds 5,056 shares of LLY stock, worth $4.58 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares

5,056

Previous 5,558 9.03%

Holding current value

$4.58 Million

Previous $3.24 Million 21.43%

% of portfolio

1.41%

Previous 1.28%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$592.2 - $792.28 $297,284 - $397,724	-502 Reduced 9.03%	5,056 $3.93 Million
Q4 2023 Jan 29, 2024	SELL	$525.19 - $619.13 $273,623 - $322,566	-521 Reduced 8.57%	5,558 $3.24 Million
Q3 2023 Oct 25, 2023	SELL	$434.7 - $599.3 $249,517 - $343,998	-574 Reduced 8.63%	6,079 $3.27 Million
Q2 2023 Jul 24, 2023	SELL	$350.74 - $468.98 $52,961 - $70,815	-151 Reduced 2.22%	6,653 $3.12 Million
Q1 2023 Apr 24, 2023	SELL	$310.63 - $364.82 $21,744 - $25,537	-70 Reduced 1.02%	6,804 $2.34 Million

Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $121,867 - $141,999	-379 Reduced 5.23%	6,874 $2.51 Million
Q3 2022 Oct 28, 2022	BUY	$296.48 - $337.87 $110,883 - $126,363	374 Added 5.44%	7,253 $2.35 Million
Q2 2022 Jul 22, 2022	SELL	$278.73 - $327.27 $278 - $327	-1 Reduced 0.01%	6,879 $2.23 Million
Q1 2022 May 04, 2022	BUY	$234.69 - $291.66 $1,877 - $2,333	8 Added 0.12%	6,880 $1.97 Million
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $16,189 - $20,090	72 Added 1.06%	6,872 $1.9 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $21,052 - $25,907	-95 Reduced 1.38%	6,800 $1.57 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $1.24 Million - $1.61 Million	6,895 New	6,895 $1.58 Million

Others Institutions Holding LLY

# of Institutions

3,721

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $862B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Freedom Day Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freedom Day Solutions, LLC with notifications on news.

Account

Freedom Day Solutions, LLC Eli Lilly & CO Transaction History